BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-706@pharmaconomics
DTSTAMP:20260707T030247Z
DTSTART;VALUE=DATE:20260309
DTEND;VALUE=DATE:20260310
SUMMARY:PLX Approval — pegunigalsidase alfa
DESCRIPTION:A final FDA approval decision on pegunigalsidase alfa for Fabry disease is expected Mar 9\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1006281/000110465926024975/plx-20260309xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/706
URL:https://pharmaconomics.com/e/706
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PLX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR